Cardioprotective Effect of Crude Extract and Solvent Fractions of Leaves on Cyclophosphamide-Induced Myocardial Injury in Rats.

BACKGROUND

Globally, cardiovascular diseases (CVDs) are becoming the major cause of death. is one of endogenous plant which treats a wide range of disease conditions including heart diseases. However, there is limited information on safety and efficacy of the plant.

OBJECTIVE

To evaluate the in vitro antioxidant, the in vivo cardioprotective activity of crude extract and solvent fractions of leaves on cyclophosphamide-induced myocardial injury.

METHODS

The cardioprotective activity of the crude extract, aqueous and hexane fraction of leaves was evaluated based on anatomical, biochemical and histopathological methods. The in vitro antioxidant activity of the plant was also assayed in terms of free radical scavenging activity (RSA).

RESULTS

Crude extract and solvent fractions of significantly prevented the deleterious effect of cyclophosphamide on body weight (P<0.001), heart weight to body ratio (P<0.01), cardiac biomarkers including troponin I (P<0.01), alanine transaminase (ALT) (P<0.001), aspartate aminotransferase (AST) (P<0.01) and lipid profiles including triglycerides (P<0.001) and total cholesterol (P<0.01). The histopathological study confirmed presence of necrosis, oedema and haemorrhage on cyclophosphamide alone-treated groups while the 200mg/kg and 400mg/kg of the crude extract and aqueous fraction showed normal cardiocytes. The antioxidant assay of plant exhibited free radical scavenging activity of inhibitory concentration of 50% (IC) for the crude extract with the values of 63.27µg/mL, aqueous fraction with the values of 136.38µg/mL and hexane fraction with the values of 258.70µg/mL.

CONCLUSION

Crude extract and solvent fractions of leaves have cardioprotective activities. The cardioprotective effect could be attributed to the antioxidant activity of the plant extracts. However, this requires further in-depth understanding.